{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T04:19:43Z","timestamp":1764562783896,"version":"3.46.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.oftale.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:05:40Z","timestamp":1758603940000},"page":"752-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy profile of the fluocinolone acetonide implant in non-infectious uveitic macular edema: 5-year follow-up"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5129-7367","authenticated-orcid":false,"given":"N.","family":"Ruiz del Rio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Garcia Ibor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gracia Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Vilaplana Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sanz Gallen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Duch Samper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2025.09.006_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oftale.2025.09.006_bib0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2025.09.006_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0300060518816884","article-title":"Intravitreal fluocinolone acetonide implant (ILUVIEN\u00ae) for diabetic macular oedema: a literature review","volume":"47","author":"Massa","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.oftale.2025.09.006_bib0020","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1007\/s10792-023-02828-6","article-title":"Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN\u00ae) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months","volume":"43","author":"Moll-Udina","year":"2023","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oftale.2025.09.006_bib0025","first-page":"665","article-title":"Long-acting fluocinolone acetonide intravitreal implant for recurrent bilateral non-infectious posterior uveitis","volume":"15","author":"Babel","year":"2022","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.oftale.2025.09.006_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/IIO.0000000000000070","article-title":"Clinical trials in noninfectious uveitis","volume":"55","author":"Kim","year":"2015","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.oftale.2025.09.006_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040688","article-title":"Biomarkers to predict the success of treatment with the intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema","volume":"14","author":"Kessler","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.oftale.2025.09.006_bib0040","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2025.09.006_bib0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12348-024-00402-4","article-title":"Fluocinolone acetonide 0.2 \u03bcg\/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations","volume":"14","author":"Pleyer","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.oftale.2025.09.006_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12348-024-00409-x","article-title":"The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience","volume":"14","author":"Kozak","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.oftale.2025.09.006_bib0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ophtha.2012.09.014","article-title":"Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2025.09.006_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/DDDT.S403259","article-title":"Intravitreal fluocinolone acetonide implant (ILUVIEN(\u00ae)) for the treatment of retinal conditions. a review of clinical studies","volume":"17","author":"Mushtaq","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.oftale.2025.09.006_bib0065","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2020.04.001","article-title":"Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results","volume":"127","author":"Jaffe","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2025.09.006_bib0070","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2147\/OPTH.S252359","article-title":"Clinical-decision criteria to identify recurrent diabetic macular edema patients suitable for fluocinolone acetonide implant therapy (ILUVIEN(\u00ae)) and follow-up considerations\/recommendations","volume":"14","author":"Ad\u00e1n","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftale.2025.09.006_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14030245","article-title":"Efficacity and safety of the fluocinolone acetonide implant in uveitic macular edema: a real-life study from the french uveitis network","volume":"14","author":"Jabbour","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.oftale.2025.09.006_bib0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3928\/23258160-20160419-05","article-title":"Characterization of intraocular pressure increases and management strategies following treatment with fluocinolone acetonide intravitreal implants in the FAME trials","volume":"47","author":"Parrish","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oftale.2025.09.006_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40123-017-0114-6","article-title":"Real-world cost savings demonstrated by switching patients with refractory diabetic macular edema to intravitreal fluocinolone acetonide (Iluvien): a retrospective cost analysis study","volume":"7","author":"Ch\u2019ng","year":"2018","journal-title":"Ophthalmol Ther"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579425001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579425001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T03:48:38Z","timestamp":1764560918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579425001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2173579425001628"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2025.09.006","relation":{},"ISSN":["2173-5794"],"issn-type":[{"type":"print","value":"2173-5794"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy profile of the fluocinolone acetonide implant in non-infectious uveitic macular edema: 5-year follow-up","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2025.07.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}